A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/28/2011	CN102296052A 一种针对ppGalNAc-T13多克隆抗体的特异性抗原肽及其制备与应用 One for ppGalNAc-T13 polyclonal antibody specific antigen peptide and its preparation and application
12/28/2011	CN102296044A 一种溶藻弧菌野生毒株的无标记基因缺失减毒突变株、相关制剂及应用 One kind of wild strains of Vibrio alginolyticus unmarked gene deletion mutants attenuated, preparation and application of the relevant
12/28/2011	CN102295703A 鉴定对用抗ErbB2抗体处理响应的肿瘤的方法 Identification of treatment with anti-ErbB2 antibody response to tumor method
12/28/2011	CN102295684A 胰岛素a链hla-a0201限制性ctl表位改造肽配体及其应用 A chain of insulin hla-a 0201 restricted epitopes ctl transformation peptide ligand and its application
12/28/2011	CN102294029A 猪瘟活疫苗的制备方法及其产品 Preparation of classical swine fever vaccine and its products
12/28/2011	CN102294028A 鸡新城疫防漏型耐热饮水免疫片及其制备方法 Newcastle leak-proof water resistant immune sheet and its preparation method
12/28/2011	CN102294027A 一种呼吸道合胞病毒f2蛋白亚单位疫苗及其制备方法 F2 a respiratory syncytial virus protein subunit vaccine and its preparation method
12/28/2011	CN102294026A 奶牛链球菌乳房炎灭活疫苗及其制备方法 Streptococcal mastitis cows inactivated vaccine and its preparation method
12/28/2011	CN102294025A 前列腺干细胞抗原多肽与核酸的复合物及其制备方法和应用 Prostate stem cell antigen peptide and nucleic acid compound and preparation method and application
12/28/2011	CN102294024A 一种多肽疫苗及其制备方法 A peptide vaccine and its preparation method
12/28/2011	CN102294023A 抗原组合物 Antigen composition
12/28/2011	CN102293743A 一种脂质微球组合物 A lipid microsphere composition
12/28/2011	CN101979542B 含CpG基序的核酸序列的制备方法及应用 Preparation and application of CpG-containing nucleic acid sequence motif
12/28/2011	CN101792759B 一种基因工程免疫刺激因子及其免疫增效的应用 A genetically engineered immune-stimulating factor and its immunity application efficiency
12/28/2011	CN101732716B 用于预防和/或治疗禽流感的抗原抗体复合物 For the prevention and / or treatment of avian influenza antigen-antibody complex
12/28/2011	CN101696242B 人源抗狂犬病毒中和抗体Fab及其制备方法和应用 Human anti-rabies virus neutralizing antibody Fab and its preparation method and application
12/28/2011	CN101684156B 人TNFα单克隆抗体、其PEG化纳米颗粒及其应用 Human TNFα monoclonal antibody PEG nanoparticles and its application
12/28/2011	CN101554477B 一种口蹄疫疫苗免疫增强剂 One kind of foot and mouth disease vaccine enhancer
12/28/2011	CN101502650B 密码子优化的乙型肝炎核酸疫苗 Codon optimized DNA vaccine of hepatitis B
12/28/2011	CN101463083B 与A-beta寡聚体特异性结合的基因工程单克隆抗体 And A-beta oligomer-specific binding of monoclonal antibodies genetically engineered
12/28/2011	CN101463082B 与A-beta寡聚体特异性结合的基因工程单克隆抗体 And A-beta oligomer-specific binding of monoclonal antibodies genetically engineered
12/28/2011	CN101376023B 一种禽用疫苗缓释剂及其制备与接种方法 One kind of poultry vaccines and vaccination release agent and its preparation method
12/28/2011	CN101368173B 抗人cd44的工程抗体、载体、试剂盒及其用途 Anti-human cd44 engineered antibody, vectors, kits and uses thereof
12/27/2011	US8084585 Anti-ILT7 antibody
12/27/2011	US8084584 Methods for stabilizing proteins
12/27/2011	US8084578 Monoclonal antibody against human scavenger receptor SRCL-P1
12/27/2011	US8084439 Methods for identifying compounds for the treatment of type 1 diabetes
12/27/2011	US8084434 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders
12/27/2011	US8084268 Method of evaluating the potential of the skin for scavenging free radicals
12/27/2011	US8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084253 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084249 Vector
12/27/2011	US8084235 Purification process for bacterial cytolysin
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody
12/27/2011	US8084200 Compositions and methods for the diagnosis and treatment of tumor
12/27/2011	US8084057 Compositions and methods for wound healing
12/27/2011	US8084044 Pseudomonas aeruginosa outer membrane protein PA0427
12/27/2011	US8084043 Subunit vaccine of Pasteurella multocida in veterinary uses
12/27/2011	US8084042 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
12/27/2011	US8084041 Use of mycrobacterial vaccines in CD4+ or CD8+ lymphocyte-deficient mammals
12/27/2011	US8084040 Use of bacterium for manufacture of a vaccine
12/27/2011	US8084039 Methods and compositions for live attenuated viruses
12/27/2011	US8084037 Recombinant parainfluenza virus expression systems and vaccines
12/27/2011	US8084036 Anchoring compound to surface of target cells; protease inhibitors
12/27/2011	US8084035 CD38 modulated chemotaxis
12/27/2011	US8084034 Proteins
12/27/2011	US8084033 Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment
12/27/2011	US8084032 Protein A chromatography; desorption via arginine and/or derivative thereof
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/27/2011	US8084030 Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA
12/27/2011	US8084029 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
12/27/2011	US8084028 Antibodies to VLA-1
12/27/2011	US8084027 Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic
12/27/2011	US8084026 Multispecific binding molecules comprising connecting peptides
12/27/2011	US8084024 Method for producing antibodies
12/27/2011	US8084020 Use of anti-CD1 antibodies for the modulation of immune responses
12/27/2011	US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide
12/22/2011	WO2011160132A2 Detection of epha3 as a marker of the presence of a solid tumor
12/22/2011	WO2011160119A2 Anti-gd2 antibodies
12/22/2011	WO2011160086A2 Use of b lymphocyte stimulator protein antagonists to treat asthma and other allergic and inflammatory conditions of the respiratory system
12/22/2011	WO2011160083A1 Antibodies useful in passive influenza immuization
12/22/2011	WO2011160078A2 Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
12/22/2011	WO2011160026A2 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
12/22/2011	WO2011159980A1 Anti-axl antibodies and methods of use
12/22/2011	WO2011159976A2 Arthritis treatment
12/22/2011	WO2011159938A2 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	WO2011159928A2 Anti-dr4 agonist antibodies
12/22/2011	WO2011159877A2 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
12/22/2011	WO2011159871A2 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
12/22/2011	WO2011159847A2 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
12/22/2011	WO2011159835A1 Antibodies to endoplasmin and their use
12/22/2011	WO2011159814A2 Novel live recombinant booster vaccine against tuberculosis
12/22/2011	WO2011159762A1 Methods of limiting microvascular damage following acute myocardial ischemia
12/22/2011	WO2011159704A1 Anti-vegf antibodies and uses thereof
12/22/2011	WO2011159655A2 IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
12/22/2011	WO2011158973A1 Novel antifibrin antibody
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158122A2 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
12/22/2011	WO2011158019A1 Polypeptide vaccine
12/22/2011	WO2011157950A1 Stabilised human immunoglobulin composition
12/22/2011	WO2011157724A1 S100a4 antibodies and therapeutic uses thereof
12/22/2011	WO2011157447A2 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	WO2011156970A1 Uses of mtea in diagnosis and treatment of malignant tumor
12/22/2011	WO2011156860A1 IMMUNOTHERAPEUTIC METHOD INVOLVING CD123 (IL-3Rα) ANTIBODIES AND IMMUNOSTIMULATING COMPLEX
12/22/2011	WO2011137422A3 Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
12/22/2011	WO2011133886A3 Production of heteromultimeric proteins
12/22/2011	WO2011133870A3 Vaccines comprising adenovirus vectors and signaling lymphocyte activating molecule-associated protein (sap)
12/22/2011	WO2011131787A3 Antibody preparations
12/22/2011	WO2011131786A3 Process for preparing an immunoglobulin composition
12/22/2011	WO2011116212A3 Bone morphogenetic protein receptor binding agents and methods of their use
12/22/2011	WO2011100408A3 Serologic correlates of protection against bacillis anthracis infection
12/22/2011	WO2011097327A3 Compositions and methods of modulating receptor protein tyrosine phosphatases
12/22/2011	WO2011094467A3 Methods of treating diabetes with dll4 antagonists
12/22/2011	WO2011088219A3 Therapeutics and processes for treatment of immune disorders
12/22/2011	WO2011082381A3 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
12/22/2011	WO2011012720A3 Compositions for generating an antigen specific immune response
12/22/2011	US20110314575 Plasmodium Vaccines, Antigens, Compositions and Methods
12/22/2011	US20110313230 Specific binding proteins and uses thereof
12/22/2011	US20110313229 Therapy Targeting Cancer Stem Cells
12/22/2011	US20110313031 Olioodeoxynucleotide and its use to induce an immune response

1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 1823